PREPARATION, CHARACTERIZATION AND EVALUATION OF POLY (LACTIDE–CO–GLYCOLIDE) MICROSPHERES FOR THE CONTROLLED RELEASE OF ZIDOVUDINE
DOI:
https://doi.org/10.22159/ijpps.2017v9i12.18377Keywords:
Zidovudine, PLGA, Microspheres, WOO double emulsion, Higuchi model, Diffusion-Controlled MechanismAbstract
Objective: The purpose of this research work was to develop and evaluate microspheres appropriate for controlled release of zidovudine (AZT).
Methods: The AZT loaded polylactide-co-glycolide (PLGA) microspheres were prepared by W/O/O double emulsion solvent diffusion method. Compatibility of drug and polymer was studied by Fourier-transform infrared spectroscopy (FTIR). The influence of formulation factors (drug: polymer ratio, stirring speed, the concentration of surfactant) on particle size encapsulation efficiency and in vitro release characteristics of the microspheres was investigated. Release kinetics was studied and stability study was performed as per ICH guidelines.
Results: Scanning electron microscopy (SEM) images show good reproducibility of microspheres from different batches. The average particle size was in the range of 216-306 μm. The drug-loaded microspheres showed 74.42±5.08% entrapment efficiency. The cumulative percentage released in phosphate Buffer solution (PBS) buffer was found to be 55.32±5.89 to 74.42±5.08 %. The highest regressions (0.981) were obtained for zero order kinetics followed by Higuchi (0.968) and first order (0.803).
Conclusion: Microsphere prepared by double emulsion solvent diffusion method was investigated and the results revealed that 216-306 μm microsphere was successfully encapsulated in a polymer. FT-IR analysis, entrapment efficiency and SEM Studies revealed the good reproducibility from batch to batch. The microspheres were of an appropriate size and suitable for oral administration. Thus the current investigation show promising results of PLGA microspheres as a matrix for drug delivery and merit for In vivo studies for scale up the technology.
Downloads
References
Athanasiou KA, Niederauer G, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996;17:93-102.
Bodmeier R, Chen H. The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery system. Int J Pharm 1989;51:1-8.
Brook I. Basic principles of drug discovery and development. J Am 1987;258:1517.
Cho JC, Khang GJ, Rhee MY, Kim S, lee JS, Lee HB. Preparation and characterization of Poly(lactide-co-glycolode) Microsphere for the sustained release of AZT. Korea Polym 1999;8:80-8.
Chow FPR, Hamburger. In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS. Eur J Haematol 1991;47:91-7.
Christoper G, Peter V, Raghavan C, Vijaya S, Hari K, Prasad R. Formulation and optimization of coated PLGA-Zidovudine nanoparticles using factorial design and in vitro in vivo evaluations to determine brain targeting efficiency. Saudi Pharm J 2014;22:133-40.
Devita VT, Broder S, Fauci AS, Kovacs JA, Chabner BA. Developmental therapeutics and the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:568–81.
Gopferich A. Polymers degradation and erosion mechanisms and applications. Eur J Pharm Biopharm 1996;42:1-11.
Gottlieb MS, Schroff R, Schanker HM. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1425-31.
ICH, Stability Testing of New Drug Substances and Products, International Conference on Harmonization IFPMA, Geneva; 2003.
Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J Controlled Release 1998;54:167-75.
Rohit RB, Riyaz Ali MO, Padmaja C, Afrasim M. Formulation and evaluation of sustained release dosage form using modified cashew gum. Int J Pharm Pharm Sci 2015;7:141-50.
Chawla SJ, Amiji MM. Biodegradable polycaprolactoe nanoparticles for tumor targeted delivery of tamoxifen. Int J Pharm Pharm Sci 2002;249:127-38.
Amann LC, Gandal MJ, Lin R, Liang Y, Siegel SJ. In vitro–in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia. Pharm Res 2010;27:1730–7.
Sandrap P, Moes AJ. Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly (DL-lactide-co-glycolide) microspheres. Int J Pharm 1993;98:157-64.
George C, Park TG. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J Controlled Release 1995;35:91-105.
Bodmer D, Kissel T, Traechslin E. Factors influencing the release of peptides and proteins from biodegradable system. J Controlled Release 1992;21:129-38.
Duan Y, Sun X, Gong T, Wang Q, Zhang Z. Preparation of DHAQ loaded MPEG-PLGA and evaluation of drug release behaviour in vitro/in vivo. J Mater Sci Mater Med 2016;17:509-16.
Zhang P, Chen L, Gu W. In vitro and invivo evaluation of donepezil–sustained release microparticles for the treatment of Alzheimers disease. Biomaterials 2007;28:1882-8.
Stolnik S, Garnett MC. The colloidal properties of surfactant free biodegradable nanospheres from (ß-malic acid–co-benzyl malate) s and poly(lactic acid-co-glycolide). Colloids Surf 1995;97:235-45.
Makino K, Ohshima H, Kondo T. Transfer of protons from bulk solution to the surface of poly(L-lactide) microsphere. J Microencaps 1986;3:195-202.
Published
How to Cite
Issue
Section
